Scaling automated nucleic acid extraction across diverse sample types in biobanking

Discover how one of Europe's leading biobanks achieve consistent, automated DNA and cfDNA extraction — across diverse sample types in biomedical research.

Managing a biobank with over two million aliquots across population cohorts, cancer registries, and cardiovascular collections demands extraction workflows that are flexible, reliable, and scalable. Dr. Ronny Baber, Head of the Leipzig Medical Biobank, faced a critical question: how do you maintain sample comparability when your collection spans dried blood spots, saliva, stool, plasma, tissue, and more? This case study reveals how the Leipzig Medical Biobank answered this challenge by implementing the chemagic 360 instrument for automated nucleic acid extraction.

Discover the qualification studies testing the instrument's performance across diverse sample types, head-to-head comparisons showing three to six-fold higher DNA yields compared to manual kits, comprehensive cfDNA extraction results, and insights into planned expansion into RNA isolation and tissue extraction workflows.

Key highlights:

• Biobank collection seize: 2 Mio aliquots
• DNA yield vs. manual competitor: 3–6× higher with the chemagic 360 instrument
• Sample types tested: Blood, buffy coat, DBS, saliva, stool, urine, plasma, tissue

Ready to see what the chemagic 360 system can do for your biobank? Download the case study now.

For research use only. Not for use in diagnostic procedures.